The biopharmaceutical company is testing with multiple U.S. military branches at Northern Strike to provide Bexson’s BB106 ketamine therapy for pain management for contested environments.
https://www.pharmalive.com/wp-content/uploads/2023/07/Bexson-Biomedical-ketamine-device.jpg600772Administratorhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAdministrator2023-07-27 14:00:542023-07-27 16:37:38Bexson Biomedical wearable ketamine device to be tested during U.S. military training exercise in August
